Method for exploring macrophage related molecular mechanism and potential therapeutic target in periodontitis

The method elucidates macrophage-related molecular mechanisms in periodontitis by using WGCNA, GO, and machine learning to identify CD39 and CXCR4 as therapeutic targets, addressing the limitations of current treatments and enhancing diagnostic precision.

CN119068998APending Publication Date: 2024-12-03CHONGQING MEDICAL UNIVERSITY

Patent Information

Application Number
CN202411101973.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing treatments for periodontitis primarily focus on removing dental plaque and using antibiotics, but they fail to restore damaged periodontal tissues, and the detailed mechanisms of host response and tissue destruction in periodontitis remain unclear, necessitating new therapeutic targets.

Method used

A method involving weighted gene co-expression network analysis (WGCNA), gene ontology (GO) and KEGG enrichment, protein-protein interaction (PPI) network analysis, and machine learning algorithms to identify key genes and pathways related to macrophage inflammation in periodontitis, followed by verification in animal and cell models.

Benefits of technology

Identifies CD39 and CXCR4 as potential therapeutic targets for managing periodontitis inflammation, validated through external datasets and models, providing insights into macrophage-related molecular mechanisms and improving diagnostic accuracy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119068998A_ABST
    Figure CN119068998A_ABST
Patent Text Reader

Abstract

The invention discloses a method for exploring macrophage related molecular mechanisms and potential treatment targets in periodontitis, and relates to the technical field of periodontitis treatment.The method comprises the following steps that S1, a data set is preliminarily screened; s2, WGCNA analysis: carrying out weighted gene co-expression network analysis on WGCNA, and importing gene expression data into a WGCNA packet of an R language for analysis; according to the method, methods such as weighted gene co-expression network analysis (WGCNA) and a machine learning algorithm are adopted; wGCNA is an efficient and comprehensive high-dimensional data analysis method, and the accuracy and effectiveness of gene chip data analysis are proved; in addition, the obtained result is verified through an external data set and a periodontitis cell animal model, so that the accuracy of the result is further improved; gSE16134 from a GEO data set is analyzed, and the result shows that CD39 is closely related to occurrence and development of periodontitis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of periodontitis treatment, and specifically to a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis. Background Art

[0002] Periodontitis is a chronic inflammatory disease that leads to connective tissue destruction and alveolar bone resorption, which may eventually cause tooth loss. The prevalence of periodontitis in my country is high and has been rising over the past decade. According to a national epidemiological survey in 2017, the proportion of edentulous patients among the elderly aged 65-74 was 4.5%, the tartar detection rate among residents aged 35-44 was 96.7%, and the gingival bleeding rate was 87.4%, an increase of 10.1% over ten years ago. Periodontitis not only causes irreversible destruction of periodontal tissues, but is also associated with a variety of systemic diseases, becoming a major burden on social medical care.

[0003] The actual driving factor of periodontitis is the interaction between dysbiosis and inflammatory response. Despite progress in the understanding of microbial factors, the detailed mechanisms of host response and tissue destruction remain elusive. The pathogenesis of periodontitis involves a variety of immune cells, among which macrophages play an important role in innate and adaptive immune responses. Macrophages maintain tissue homeostasis and inflammation resolution by phagocytizing pathogens and debris, releasing cytokines and chemokines, and presenting antigens to T cells. Traditional treatments mainly remove dental plaque, including non-surgical treatments (such as supragingival scaling, root planing) and periodontal surgery, and the use of antibiotics. Although these methods can control periodontitis, it is difficult to restore damaged periodontal tissues. Therefore, finding new therapeutic targets remains an urgent problem to be solved.

[0004] In view of this, a method for exploring the macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis is provided to overcome the above problems. Summary of the invention

[0005] The purpose of the present invention is to provide a method for exploring the macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis, so as to solve the problems raised in the above-mentioned background technology.

[0006] In order to solve the above technical problems, the present invention provides a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis, comprising the following steps:

[0007] S1, preliminary screening of the dataset;

[0008] S2. WGCNA analysis: weighted gene co-expression network analysis (WGCNA) was performed, and the gene expression data were imported into the WGCNA package of R language for analysis;

[0009] S3. GO and KEGG enrichment analysis: GO and KEGG functional enrichment analysis was performed on the screened macrophage inflammatory gene modules;

[0010] S4. Construct a PPI network of target protein interactions and screen core targets: According to the comparison results of step S3, select genes in the GO enrichment analysis and KEGG pathway enrichment results that have passed preliminary verification; import these genes into the STRING database to generate a PPI network diagram of protein interactions; then import the results into the Cytoscape software to analyze the characteristic parameters of the network nodes, determine the screening conditions for the core targets, and identify the core targets;

[0011] S5. Screening of key genes through machine learning algorithms;

[0012] S6, determine the key genes: take the intersection genes of the genes in step S4 and step S5;

[0013] S7. Gene set enrichment analysis: The samples were divided into low expression group and high expression group according to the expression level of key genes; the selected reference gene set was downloaded from the molecular signature database to determine the potential mechanism of key genes involved in the pathogenesis of periodontitis;

[0014] S8. Verification of key gene expression: Construct periodontitis animal model and macrophage inflammation model to detect the expression level of key genes.

[0015] Furthermore, in S1, datasets related to periodontitis were retrieved from the GEO public database and inflammation-related genes were integrated, and the data expression of periodontitis and the corresponding clinical sample information were downloaded. The inflammation-related genes were obtained from the Genecards database.

[0016] Furthermore, in S1, the dataset quality was checked and data cleaning was performed: the norma li zeBetweenArrays method of the R language limma package was used to normalize the periodontitis chip expression data, and the differentially expressed genes (DEGs) between the periodontitis samples and the control group were identified by the Limma software package, with |log2FC|>1 and adj.p<0.05 as the cutoff values.

[0017] Furthermore, in S3, based on the WGCNA analysis results, the module genes with the highest correlation were selected and imported into R language, and GO analysis and KEGG pathway enrichment analysis were performed using classerProfilerGO.R and classerProfilerKEGG.R, respectively, and the results were visualized.

[0018] Furthermore, in S5, multiple feature selection algorithms, including LASSO, SVM-RFE, and Boruta, were used to investigate the important diagnostic biomarkers involved in macrophage inflammation in periodontitis.

[0019] Furthermore, in S8, external datasets and the construction of periodontitis cell and animal models were used to verify the differential expression of core genes in the disease group and the control group.

[0020] Further, in S8, the potential biomarker selected was CD39.

[0021] Furthermore, in S8, the selected potential biomarkers also include CXCR4.

[0022] Compared with the prior art, the present invention has the following beneficial effects:

[0023] Methods such as weighted gene co-expression network analysis (WGCNA) and machine learning algorithms were used; WGCNA is an efficient and comprehensive high-dimensional data analysis method, and its accuracy and effectiveness in analyzing gene chip data have been confirmed; in addition, the results were verified by external data sets and periodontitis cell animal models, further improving the accuracy of the results.

[0024] GSE16134 from the GEO dataset was analyzed, and the results showed that CD39 was closely related to the occurrence and development of periodontitis. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 This is a diagram for identifying differentially expressed genes in periodontitis in a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to the present invention;

[0026] Figure 2 A network analysis diagram of macrophage infiltration and weighted gene co-expression in a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to the present invention;

[0027] Figure 3 This is a diagram of differentially expressed genes and functional enrichment of macrophage inflammation in periodontitis in a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis of the present invention;

[0028] Figure 4 A key macrophage inflammatory gene map in periodontitis in a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis of the present invention;

[0029] Figure 5 This is a diagram of key gene function analysis in a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to the present invention;

[0030] Figure 6 A relative expression graph of key genes in a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to the present invention;

[0031] Figure 7 This is a diagram verifying the expression of CD39 in periodontitis cells and animal models in a method of the present invention for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis. DETAILED DESCRIPTION

[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] See also Figure 1-Figure 7 , the present invention provides a technical solution:

[0034] Figure 1 a in the figure is: volcano plot of differentially expressed genes between control and periodontitis samples; b is: heat map of the top 10 differentially expressed genes between control and periodontitis samples;

[0035] Figure 2 a is a violin plot comparing the abundance of macrophages between groups; b is screening for appropriate soft thresholds and scale-free network validation; c is a clustering dendrogram with gene modules and module merging; d is the correlation between gene modules and clinical characteristics;

[0036] Figure 3 a in the middle is: macrophage inflammation differentially expressed genes; b is: GO enrichment analysis; c is: KEGG enrichment analysis;

[0037] Figure 4 Figure a: Identification of core genes in the PPI network; b: A key cluster of 24 genes was further selected through the MCODE plug-in; c: The top 15 genes screened in the CYTOHUBBA plug-in using the MCC algorithm;

[0038] d: 28 genes were identified as significant features by LASSO regression; e: 16 genes were screened by SVM-RFE; f: 65 genes were identified as important features by Boruta algorithm; g: intersection genes CD39 (ENTPD1) and CXCR4;

[0039] Figure 5 Middle ab are the functional pathways of CXCR4 and CD39 involved in periodontitis analyzed using GSEA;

[0040] Figure 6 a in the figure is: the expression difference of key genes in GSE16134; bc is: the expression difference of key genes in the validation dataset GSE10334 and GSE23586;

[0041] Figure 7 ab in the middle are: WB detection of CD39 expression in periodontitis mice; c is: qRT-PCR detection of CD39 expression in PD mice; de ​​is: WB detection of CD39 expression in Pg-LPS-stimulated cells 24 hours later; f is: qRT-PCR detection of CD39 expression in Pg-LPS-stimulated cells 24 hours later;

[0042] See also Figure 1 -

[0043] Figure 7 As shown, a method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis comprises the following steps:

[0044] S1. Preliminary screening of data sets: Data sets related to periodontitis were retrieved from the GEO public database and inflammation-related genes were integrated. The data expression of periodontitis and the corresponding clinical sample information were downloaded. Inflammation-related genes were obtained from the Genecards database. Data set quality inspection and data cleaning: The normasizeBetweenArrays method of the R language limma package was used to standardize the periodontitis chip expression data, and the differentially expressed genes (DEGs) between the periodontitis samples and the control group were identified using the Limma software package, with |log2FC|>1 and adj.p<0.05 as the cutoff values.

[0045] Specifically: We downloaded GSE16134, GSE10334, and GSE23586 datasets from the GEO database. GSE16134 contains RNA expression profiles of 310 samples, including 241 PD samples and 69 control samples; G SE10334 contains 247 samples, including 183 PD samples and 64 control samples; GSE23586 contains 6 samples, including 3 samples from healthy people and 3 samples from periodontitis patients; Inflammation-related genes are from the Genecards database (https: / / www.genecards.org / ); This study was conducted in R (version 4.2, https: / / www.r-project.org / );

[0046] ssGSEA analysis: We used the gene expression levels in the GSE16134 dataset and the ssGSEA method in R language to analyze the enrichment level of macrophages in each sample, and used the ggp l ot2 package to show the differences in macrophage expression levels in different samples;

[0047] S2. WGCNA analysis: weighted gene co-expression network analysis WGCNA was performed, and the gene expression data were imported into the WGCNA package of R language for analysis; in the specific implementation, the WGCNA model was used to screen gene modules related to periodontitis, inflammation-related gene modules and macrophage-related gene modules; the WGCNA method was used to construct a weighted gene co-expression network;

[0048] Specifically: The WGCNAR package was used to construct a gene co-expression network, calculate the Pearson correlation value and construct a gene matrix, select β = 6 as an appropriate soft threshold to construct a highly connected scale-free network, and generate a topological overlap matrix (TOM) to estimate network connectivity; at the same time, a hierarchical clustering tree diagram of the TOM matrix was established, the minimum module size of the gene tree diagram was set to 30, and the truncation threshold was set to <0.25 to merge high similarity modules; finally, the ssGSEA analysis results were combined with inflammation-related genes to calculate the gene significance (GS) of the correlation between genes and disease phenotypes, immune cell scores and inflammation, and the module membership (MM) of the correlation between genes and gene modules, and macrophage-related genes (MRGs) and inflammation important module genes (IRGs) were screened according to the absolute value of the correlation coefficient;

[0049] S3. GO and KEGG enrichment analysis: GO and KEGG functional enrichment analysis was performed on the screened macrophage inflammatory gene module; specifically, based on the WGCNA analysis results, the module genes with the highest correlation were selected, imported into the R language, and clusterProfilerGO.R and clusterProfilerKEGG.R were used to perform GO analysis and KEGG pathway enrichment analysis respectively, and the results were visualized;

[0050] More specifically: GO enrichment analysis (including MF, BP and CC) and KEGG pathway analysis were performed on the differentially expressed genes and macrophage inflammation module genes in periodontitis; the analysis was performed based on the "ClusterProfiler" package, org.Hs.eg.db package and the enrichplot package of R software, with log2formchange(logFC)|>1 and p value<0.05 as the criteria for determining significant results;

[0051] S4. Construct a PPI network of target protein interactions and screen core targets: According to the comparison results of step S3, select genes in the GO enrichment analysis and KEGG pathway enrichment results that have passed preliminary verification; import these genes into the STRI NG database to generate a PPI network diagram of protein interactions; then import the results into the Cytoscape software to analyze the characteristic parameters of the network nodes, determine the screening conditions for the core targets, and identify the core targets;

[0052] Specific:

[0053] The STRI NG database (https: / / str i ng-db.org / ) was used to perform PPI network analysis on macrophage inflammation differential genes, and Cytoscape 3.9.1 was used to visualize the interactions as a network. The Molecular Complex Detection (MCODE) plug-in of Cytoscape and the MCC algorithm of the Cytohubba plug-in were used to screen the key genes in the PPI network.

[0054] S5. Key gene screening by machine learning algorithms: Multiple feature selection algorithms, including LASSO, SVM-RFE, and Boruta, were used to study important diagnostic biomarkers involved in macrophage inflammation in periodontitis;

[0055] Specific:

[0056] We used multiple feature selection algorithms, including LASSO, SVM-RFE, and Boruta, to investigate important diagnostic biomarkers involved in macrophage inflammation in periodontitis; LASSO binomial regression nested cross validation was used to select the best predictors, using the glmnet R package. The caret package was used for the SVM-RFE algorithm, which is based on backward feature elimination and recursively removes the lowest-ranked features. The Boruta algorithm built around random forests was also used to remove irrelevant and redundant features using the Boruta package in R, where variables labeled “Conf i rmed” were identified; the results of the Boruta algorithm were visualized using the ggstatsp l ot R package; based on these results, the final key genes CD39 and CXCR4 were obtained by intersecting the MIDEGs identified by LASSO, SVM-RFE, and Boruta with the key gene clusters identified by the PPI network;

[0057] S6, determine the key genes: take the intersection genes of the genes in step S4 and step S5;

[0058] S7. Gene set enrichment analysis: The samples were divided into low expression group (<50%) and high expression group (≥50%) according to the expression level of key genes; the selected reference gene set was downloaded from the Molecular Signature Database (MSi gDB) to determine the potential mechanism of key genes involved in the pathogenesis of periodontitis;

[0059] Specific:

[0060] GSEA was used to identify the potential functions of key genes; samples were divided into low expression group (<50%) and high expression group (≥50%) according to the expression levels of key genes in GSE16134; the selected reference gene set was downloaded from the Molecular Signature Database (MSigDB); p values ​​were obtained by comparing the enrichment scores with the enrichment results generated by 1000 random permutations of the gene set, with p < 0.05 as significant, and GSEA analysis was performed using default parameters;

[0061] Cell and animal model experiments were conducted: RAW264.7 mouse macrophages were selected and cultured in DMEM medium containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin in a 37°C, 5% CO2 incubator; the inflammatory cell model was constructed by stimulating Porphyromonas gingivalis lipopolysaccharide; C57BL / 6 mice (age, 6 weeks old, body weight, ≥20g) were from Chongqing Medical University; all mice were housed in a specific pathogen-free environment; the mice were randomly divided into four groups, including blank control (healthy mice without periodontitis) (control group) and periodontitis mice; we established a periodontitis mouse model based on previous studies; briefly, a 5-0 silk suture was ligated on the maxillary left second molar (M2) of anesthetized mice; the ligature was placed for 6, 12, and 18 days to induce periodontitis;

[0062] S8. Expression verification of key genes: construct periodontitis animal models and macrophage inflammation models to detect the expression levels of key genes. Specifically, use external data sets and construct periodontitis cell and animal models to verify the differential expression of core genes in the disease group and the control group. The potential biomarkers selected are CD 39 (ENTPD1) and CXCR4.

[0063] Specific:

[0064] The gingival tissue of mice was taken out, and the total protein was extracted. The expression of CD39 in the tissue was detected by Western blot. The results showed that the level of CD39 in the gingival tissue of mice in the periodontitis group increased at P6, P12, and P18. The total RNA in the gingival tissue of mice was extracted, and the transcription level of CD39 in the tissue was detected by qPCR after reverse transcription. The results showed that compared with healthy mice, the transcription level of CD 39 in the gingival tissue of mice in the periodontitis group was increased. Mouse macrophages (RAW264.7) were cultured in DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin in an incubator at 37°C and 5% CO2. After 24 hours of stimulation with or without LPS, the total protein and RNA were extracted, and the expression of CD39 was detected by Western blot and qPCR. The results showed that the expression of CD39 in the LPS treatment group was increased.

[0065] Summarize:

[0066] This study aimed to elucidate the molecular mechanisms of macrophages in periodontitis. We used bioinformatics methods to identify differentially expressed genes (DEGs) associated with macrophage inflammation in patients with periodontitis and compared them with healthy controls. We performed protein-

[0067] Protein-protein interaction (PPI) network analysis, gene co-expression network analysis, and functional enrichment analysis were performed to identify key genes and pathways involved in the inflammatory response; in addition, we performed validation based on the expression of hub genes in external datasets and periodontitis cell and animal models to improve the accuracy of periodontitis diagnosis; our results provide new insights into the role of macrophages in periodontal disease and highlight potential therapeutic targets for managing periodontitis inflammation.

Claims

1. A method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis, characterized in that: The following steps are involved: S1, preliminary screening of the dataset; S2. WGCNA analysis: weighted gene co-expression network analysis (WGCNA) was performed, and the gene expression data were imported into the WGCNA package of R language for analysis; S3. GO and KEGG enrichment analysis: GO and KEGG functional enrichment analysis was performed on the screened macrophage inflammatory gene modules; S4. Construct a PPI network of target protein interactions and screen core targets: According to the comparison results of step S3, select genes in the GO enrichment analysis and KEGG pathway enrichment results that have passed preliminary verification; These genes were imported into the STRING database to generate a PPI network diagram of protein interactions; the results were then imported into the Cytos cape software to analyze the characteristic parameters of the network nodes, determine the screening conditions for the core targets, and identify the core targets; S5. Screening of key genes through machine learning algorithms; S6, determine the key genes: take the intersection genes of the genes in step S4 and step S5; S7. Gene set enrichment analysis: The samples were divided into low expression group and high expression group according to the expression level of key genes; the selected reference gene set was downloaded from the molecular signature database to determine the potential mechanism of key genes involved in the pathogenesis of periodontitis; S8. Verification of key gene expression: Construct periodontitis animal model and macrophage inflammation model to detect the expression level of key genes.

2. A method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to claim 1, characterized in that: In S1, periodontitis-related datasets were retrieved from the GEO public database and inflammation-related genes were integrated, and the data expression of periodontitis and the corresponding clinical sample information were downloaded. Inflammation-related genes were obtained from the Genecards database.

3. A method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to claim 1, characterized in that: In S1, data set quality inspection and data cleaning were performed: the normalizeBetweenArrays method of the limma package in R language was used to normalize the periodontitis chip expression data, and the differentially expressed genes (DEGs) between the periodontitis samples and the control group were identified by the Limma software package, with |log2FC|>1 and adj.p<0.05 as the cutoff values.

4. A method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to claim 1, characterized in that: In S3, based on the WGCNA analysis results, the module genes with the highest correlation were selected and imported into R language. GO analysis and KEGG pathway enrichment analysis were performed using clusterProfilerGO.R and clusterProfilerKEGG.R, respectively, and the results were visualized.

5. A method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to claim 1, characterized in that: In S5, multiple feature selection algorithms, including LASSO, SVM-RFE, and Boruta, were used to investigate the important diagnostic biomarkers involved in macrophage inflammation in periodontitis.

6. A method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to claim 1, characterized in that: In S8, external datasets and construction of periodontitis cell and animal models were used to verify the differential expression of core genes in the disease group and the control group.

7. A method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to claim 6, characterized in that: In S8, the potential biomarker selected was CD39.

8. A method for exploring macrophage-related molecular mechanisms and potential therapeutic targets in periodontitis according to claim 7, characterized in that: In S8, CXCR4 was also included in the selected potential biomarkers.

Citation Information

Patent Citations

  • Early marker for predicting heart failure caused by myocardial infarction, prognosis model and application thereof

    CN117265098A

  • Methods of treating or preventing periodontitis and diseases associated with periodontitis

    US20130034568A1

Cited By

  • Application of EHD3 and ATP6V1E1 as marker and therapeutic target for predicting progression of periodontal disease

    CN119881342A